Get the Stockscreener App
18.77
4.92%
0.88
Pre-market:
18.64
-0.13
-0.69%
Tandem Diabetes Care Inc stock is traded at $18.77, with a volume of 1.94M.
It is up +4.92% in the last 24 hours and down -42.97% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$17.89
Open:
$18.57
24h Volume:
1.94M
Relative Volume:
1.38
Market Cap:
$1.25B
Revenue:
$796.00M
Net Income/Loss:
$-136.49M
P/E Ratio:
-8.9809
EPS:
-2.09
Net Cash Flow:
$-64.24M
1W Performance:
-1.78%
1M Performance:
-42.97%
6M Performance:
-57.11%
1Y Performance:
-37.25%
1-Day Range:
$18.03
$19.34
1-Week Range:
$17.64
$19.51
52-Week Range:
$17.64
$53.69
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
18.77 | 1.25B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Tandem Diabetes Care (NASDAQ:TNDM) Trading Up 6.1% Following Insider Buying Activity - Defense World
Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings - MSN
Victory Capital Management Inc. Decreases Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Bank of New York Mellon Corp Purchases 4,130 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes Care’s SWOT analysis: stock outlook amid market challenges - Investing.com
Keybank National Association OH Has $245,000 Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes EVP Kyrillos purchases $190,966 in company stock By Investing.com - Investing.com South Africa
Tandem Diabetes EVP Kyrillos purchases $190,966 in company stock - Investing.com India
Reasons to Hold TNDM Stock in Your Portfolio for Now - Yahoo Finance
Tandem Diabetes Care: A Buy Rating Backed by Growth Potential and Valuation Opportunity - TipRanks
Smartleaf Asset Management LLC Acquires 1,101 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes Care, Inc. to Host Earnings Call - ACCESS Newswire
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by US Bancorp DE - Defense World
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Oppenheimer & Co. Inc. - Defense World
TANDEM DIABETES CARE, INC. (NASDAQ:TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. - ACCESS Newswire
Tandem Diabetes Care stock hits 52-week low at $18.27 By Investing.com - Investing.com Australia
Tandem Diabetes Care stock hits 52-week low at $18.27 - Investing.com
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Position Increased by Private Advisor Group LLC - Defense World
Morgan Stanley Downgrades Tandem Diabetes Care (NASDAQ:TNDM) to Equal Weight - Defense World
Tandem Diabetes Care (NASDAQ:TNDM) Rating Lowered to Neutral at Citigroup - Defense World
Morgan Stanley Downgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes Care downgraded to Equal-weight on guidance concerns - MSN
Tandem Diabetes Care Shares Edge Lower After Downgrade From Morgan Stanley -March 05, 2025 at 02:34 pm EST - Marketscreener.com
Morgan Stanley Downgrades Tandem Diabetes Care (LSE:0M0F) - Nasdaq
This H.B. Fuller Company Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga India
Tandem Diabetes stock downgraded at Morgan Stanley (TNDM:NASDAQ) - Seeking Alpha
Morgan Stanley Downgrades Tandem Diabetes Care to Equalweight From Overweight, Adjusts PT to $22 From $45 - Marketscreener.com
Automated Insulin Delivery Technology Receives FDA Clearance for Individuals With Type 2 Diabetes - Pharmacy Times
Citigroup Downgrades Tandem Diabetes Care (TNDM) - MSN
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023TNDM - ACCESS Newswire
Citigroup Downgrades Tandem Diabetes Care (LSE:0M0F) - Nasdaq
Citigroup Downgrades Tandem Diabetes Care to Neutral From Buy, Adjusts Price Target to $24 From $35 - Marketscreener.com
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Lowered to $24.00 at The Goldman Sachs Group - Defense World
Tandem Diabetes Care (NASDAQ:TNDM) Receives “Equal Weight” Rating from Wells Fargo & Company - Defense World
Tandem Diabetes Care (NASDAQ:TNDM) Shares Down 5.5% Following Analyst Downgrade - Defense World
Tandem Shares Fall After Downgrades From Wells Fargo, Bernstein -March 03, 2025 at 02:38 pm EST - Marketscreener.com
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – TNDM - ACCESS Newswire
Wells Fargo Downgrades Tandem Diabetes Care (TNDM) - MSN
Wells Fargo Downgrades Tandem Diabetes Care to Equalweight From Overweight, Adjusts Price Target to $22 From $38 - Marketscreener.com
Bernstein Downgrades Tandem Diabetes Care to Market Perform From Outperform, $35 Price Target - Marketscreener.com
Reasons to Retain TNDM Stock in Your Portfolio for Now - MSN
Leerink Partnrs Issues Positive Forecast for TNDM Earnings - Defense World
(TNDM) Technical Pivots with Risk Controls - Stock Traders Daily
FY2029 Earnings Estimate for TNDM Issued By Leerink Partnrs - Defense World
Sanford C. Bernstein Downgrades Tandem Diabetes Care (NASDAQ:TNDM) to Market Perform - Defense World
Barclays Lowers Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $53.00 - Defense World
Robert W. Baird Issues Pessimistic Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price - Defense World
Royal Bank of Canada Lowers Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $55.00 - Defense World
INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Tandem Diabetes Care, Inc.(TNDM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - MSN
Royal Bank of Canada Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $55.00 - MarketBeat
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.08%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):